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ABSTRACT 
 
This study aims to evaluate the effects of short-term sodium phosphate intake 
upon body composition, haemogram, maximal ergospirometer parameters and 
submaximal ones in the maximal fat oxidation zone (Fatmax). 20 active subjects 
participated in this study randomly divided into two groups: The experimental 
group which ingested sodium phosphate for 7 days (50 mg/kg lean mass) and 
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the placebo group. Both performed an incremental maximal cycle ergo meter 
test following the Fatmax protocol, body composition assessment and blood 
analysis (CBC) before and after the supplementation period. In the experimental 
group, phosphate supplementation produced a decrease in weight and body 
mass index (BMI), an increase in maximal power output and it also improved 
energy efficiency in the Fatmax zone. No changes were observed in the 
parameters listed in the CBC. These results may attribute an ergogenic effect of 
sodium phosphate in aerobic activities and sports where body weight is 
considered to be an important factor for performance. 
 
KEY WORDS: dietary sport supplement, fat mass, BMI, haematocrit, VO2max, 
power, energy expenditure. 
  
RESUMEN  
 
Este estudio pretende evaluar los efectos de la ingesta de fosfato sódico 
a corto plazo, sobre la composición corporal, serie roja y parámetros 
ergoespirométricos máximos y submáximos. A una muestra de 20 sujetos 
físicamente activos, separados en dos grupos, se les suministró fosfato sódico 
durante 7 días (50 mg/kg masa magra) o placebo. Ambos grupos realizaron una 
prueba de esfuerzo incremental máxima en cicloergómetro, siguiendo el 
protocolo Fatmax, se les determinó la composición corporal y se les realizó un 
hemograma antes y después de la suplementación. En el grupo experimental, 
se observó una disminución en el peso e índice de masa corporal (IMC), un 
aumento en la potencia máxima alcanzada y una mejor eficiencia energética en 
la zona Fatmax. No se observaron cambios en parámetros hematológicos. Estos 
resultados pueden atribuir un efecto ergogénico al fosfato sódico en actividades 
aeróbicas y aquellas donde el peso corporal influya en el rendimiento. 
 
PALABRAS CLAVE: ayuda ergogénica, masa grasa, IMC, hematocrito, VO2max, 
potencia, gasto energético. 
 
 
INTRODUCTION  
 
Phosphate salts are classified as potentially ergogenic substances and are 
permitted by sports law. There are many benefits attributed to them because 
they are involved in many metabolic processes. In exercise, these salts play a 
very important role as they are involved in the three energy systems. 
Phosphates are part of ATP and creatine phosphate (CP), which are basic 
substrates of high energy phosphagen. They are also involved in anaerobic 
glycolysis, softening acid lactic effects in speed endurance exercises, and they 
are actively involved in the aerobic energy system (Czuba, Zając, Poprzecki & 
Cholewa, 2008; Williams, 1998).  
 
Kreider, Miller, Williams, Somma & Nasser (1990) examine different hypotheses 
for which phosphate supplements may affect performance athletes. Firstly, 
there would be a general metabolic improvement because the mentioned 
supplements increase intracellular and extracellular concentrations of 
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phosphate and produce improvements in glycolysis and glycogenolysis in 
oxidative phosphorylation, causing an ergogenic effect, enhancing energy 
metabolism and / or energy efficiency. Furthermore, supplementation also 
provides additional inorganic phosphate to replenish ATP and CP during 
exercise (Stryer, 1988). In endurance exercise an ergogenic benefit may be 
witnessed, improving efficiency and / or cardiovascular performance, enhancing 
peripheral oxygen extraction (Farber, Carlone, Palange, Serra, Paoletti & 
Fineberg, 1987) and reducing cardiac submaximal expenditure (Farber, 
Sullivan, Fineberg, Carlone & Manfredi, 1984; Lunne, Zauner, Cade, Wright & 
Conte, 1990).  
 
One of the first studies on this method was carried out by Cade, Conte, Zauner, 
Mars, Peterson, Lunne, Hommen & Packer (1984). In this study ten trained 
male runners took sodium phosphate or placebo supplements and then they 
performed a stress test. The results revealed an increase in VO2max, 
depending on the order in which the substances are taken, increasing more in 
those subjects taking phosphate in two consecutive tests. These results provide 
the first evidence that sodium phosphate supplementation could improve the 
capabilities of well-trained athletes.   
 
Kreider et al. (1990, 1992) performed other research projects, one of them with 
elite athletes and another with elite cyclists, where they observed that sodium 
phosphate intake increases VO2max and the ventilatory anaerobic threshold. In 
Stewart, McNaughton, Davies & Tristram (1990) eight trained male cyclists took 
sodium phosphate over three days, before carrying out a maximal test. There 
were significant increases in VO2max and they were able to stand higher loads 
during the test. 
  
Recently, studies with trained cyclists have shown significant increases in 
average power and oxygen volume (Folland, Stern y Brickley, 2008), and 
decreases in maximum heart rate and resting (Czuba, Zajac, Poprzecki & 
Cholewa, 2008).  
 
There are many different protocols carried out to observe the effects of 
phosphate supplementation. However, there is no unanimity regarding results, 
therefore, Buck, Wallman, Dawson y Guelfi (2013), in their review about this 
subject, indicate that it is important to assess the results as they could be 
influenced by the differences between the types of supplements or the fitness 
level of participants in the studies.  
 
There is some controversy regarding the study protocols used, taking maximum 
data in some cases and submaximal data in other cases. For this reason it 
would be necessary to obtain data relating to the entire course of the test. In 
this sense, during an incremental exercise test the intensity at which the 
subjects reach the fat burning peak, known by the name of Fatmax, could be 
determined (Jeukendrup & Acthen, 2001; Achten, Gleeson & Jeukendrup, 
2002). This can be found at an exercise intensity between 33% and 65% of 
VO2max (Jeukendrup & Acthen, 2001; Venables, Achten & Jeukendrup, 2005) 
but it is not possible to find studies linking phosphate supplementation with 
metabolic substrate utilisation.  
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The fact that different benefits during physical activity may occur, such as 
general metabolic improvement and improved cardiovascular efficiency, both 
mentioned above, might suggest that there will be several changes in the 
parameters related to red blood series or even in the body composition of 
subjects. No founding research related to the study of these parameters has 
been found and thus, it would be interesting to obtain them for analysis and 
study.  
 
The aim of this research is to evaluate the potential ergogenic effect of sodium 
phosphate supplementation in physically active subjects, by analysing blood cell 
count, body composition and different ergospirometric parameters (VO2, VCO2, 
RER, heart rate and power) at their maximal and submaximal values in the 
Fatmax zone.  
 
MATERIAL & METHODS  
 
Participants 
 
The subjects involved in this study were 20 physically active male subjects, who 
performed weekly physical activity but did not follow any training protocol. The 
physical activity carried out by the subjects was not done with a high 
performance objective, and was observed after assessing the subjects via the 
IPAQ survey (Craig, Marshall, Sjostrom, Bauman, Booth & Ainsworth, 2003). All 
the participants in the study were previously informed of the protocol and signed 
a voluntary consent form, ensuring confidentiality of data. All were committed to 
maintaining a diet similar to the usual. The study complied with the principles of 
the Declaration of Helsinki and its previous reviews on human studies.  
 
The subjects were randomly divided into two groups: the experimental and 
placebo group. The baseline characteristics of the sample are shown in Table 1.  
 
Table 1. Participant Characteristics 
 Experimental Group Placebo Group 
Age (years) 23,4±2,3 24±3,5 
Physical Activity 
(hours/week) 
5,3±1,8 6,8±1,7 
Height (cm) 174,7±7,6 180±4,5 
Weight (kg) 73,0±10,1 72,6±6,9 
Fat Free Mass (MLG) (kg) 61,4±7,1 62,6±5,3 
Fat Mass (MG) (kg) 11,6±3,4 10,0±2,5 
IMC 23,8±1,9 22,3±1,8 
 
Experimental Protocol 
 
A protocol was developed for all the subjects to undertake the study under 
similar conditions. The subjects were submitted to an interview where they 
answered various questions and the experimental protocol was explained, so 
that all subjects had a general idea of the whole process which would take 
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place. The most relevant answers to our study were the number of hours of 
physical activity, in order to check that they really were not high-level trained 
athletes.  
 
The sample was randomly divided into two groups: the experimental group took 
tribasic sodium phosphate three times daily for a week. The doses were 
prepared taking into account the fat free mass of subjects (50mg/kg), as did 
Minson (2000) and Czuba, Zajac, Poprzecki & Cholewa (2008). The placebo 
group took 50mg/kg of a fat-free mass of sodium bicarbonate, also three times 
daily for a week. There were twenty-one doses in capsules for both groups, in 
order to avoid the subjects being able to identify the substance they were 
taking. 
 
Before starting their intake, the subjects performed the following protocol. All 
participants were given an appointment at the Laboratory of Physiology at the 
University of Extremadura, during the same time slot (between 9 and 11 am) 
and without food intake. They conducted an assessment of body composition 
by bio impedance (Tanita® BF-350). The collected parameters were: weight 
(kg), fat mass (kg and % of total weight), fat mass (kg and % of total weight), 
body water (kg and % of total weight) and BMI (body mass index).  
 
A blood sample was taken from the antecubital vein to obtain two 10 ml tubes 
which were used to immediately perform a complete blood count (Coulter Ac.T) 
the collected data were: haematocrit (%), haemoglobin (g / dL), RBC (x10 ̑ 
3/uL), mean corpuscular volume (fL). 
 
Subjects were allowed to take a standardised breakfast and an hour later 
performed a cycle ergometer exercise test (ERGO-METRICS 900) following the 
adapted Fatmax protocol (Achten, Gleeson & Jeukendrup, 2002). The exercise 
test began with a load of 100W and was increased by 25W every 3 minutes 
until they could not maintain the intensity of effort. Throughout the test the 
ventilatory response was recorded by a gas analyser (CORTEX METAMAX) 
and heart rate with a heart rate monitor (Polar ® S610i). The spirometric 
response was collected every 20 seconds. 
  
The data collected for further analysis were those related to relative oxygen 
consumption (ml / min / kg), CO2 production (l / min) respiratory quotient (RER), 
heart rate (bpm), reserve heart rate percentage and power (W) at maximum 
parameters and those reached in the Fatmax zone. This area was determined 
following principles of indirect calorimetry, as carbohydrates, fats and proteins 
have different chemical compositions and therefore need different amounts of 
oxygen, and produce different amounts of carbon dioxide to be oxidized, which 
allows areas in which one type of substrate or another dominates, to be 
analysed (Jeukendrup & Wallis, 2005). To calculate the values obtained at each 
stage of the test and Fatmax zone the average data for each step of the 
exercise test was recorded. 
 
After a week of supplementation, phosphate or placebo, the subjects undertook 
the same protocol (body composition assessment, blood sampling and an 
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incremental exercise test). In this way, the initial use of metabolic substrates 
during testing being influenced or conditioned by prior exercise was prevented, 
carrying out similar energy expenditure in the two tests, due to being separated 
in time (Jeukendrup &Walls, 2005). 
 
Data analysis 
 
Once all the data was collected SPSS 19.0 was used and a data normality 
study was carried out using the Kolmogorov-Smirnov test. 
 
  As the data did not meet the normal data criteria a nonparametric statistical 
test was performed in order to evaluate the effects of sodium phosphate intake. 
The Wilcoxon test was used for 2 related samples, with differences of p <0.05 
being regarded as significant. Results were expressed as mean ± standard 
deviation.  
 
RESULTS 
 
The results obtained in the study may be seen below. Table 2 shows detailed 
data of body composition before and after the intake of sodium phosphate or 
placebo.  
  
Table 2. Body composition before and after intake of placebo or sodium phosphate 
 
VARIABLE EXPERIMENTAL GROUP  PLACEBO GROUP  
 Pre-
Ingestion 
Post-
Ingestion 
Sig. Pre-
Ingestion 
Post-
Ingestion 
Sig. 
Weight (kg) 73,08±10,15 72,63±9,96* 0,024 72,62±6,91 73,24±6,80 0,075 
 IMC 
(weight/height2) 
23,84±1,99 23,70±1,95* 0,044 22,39±1,88 22,59±1,91 0,079 
Fat Free Mass 
(FFM) (kg) 
61,46±7,10 61,48±7,03 0,799 62,60±5,37 63,16±5,20 0,079 
Fat Mass (FM) 
(kg) 
11,62±3,45 11,15±3,20 0,059 10,02±2,53 10,07±2,50 0,799 
Water (kg) 45,00±5,21 45,00±5,14 0,959 45,84±3,92 46,25±3,80 0,090 
% FFM 84,41±2,81 84,92±2,51 0,092 86,32±2,79 86,35±2,72 0,799 
% FM 15,61±2,82 15,08±2,50 0,074 13,69±2,78 13,64±2,71 0,674 
% Water 61,78±2,04 62,15±1,86 0,092 63,19±2,05 63,22±1,99 0,733 
p<0,05 comparing Pre-ingesta vs. Post-ingesta  
  
As is observed, after supplementation with sodium phosphate a statistically 
significant decrease in body weight and BMI occurs in subjects from the 
experimental group, unlike those from the placebo group who experienced a 
slight increase in both parameters. 
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Table 3 shows the results obtained after performing blood counts before and 
after the ingestion of sodium phosphate or placebo. 
 
Table 3. Haematological values before and after intake of placebo or sodium phosphate 
 
VARIABLE EXPERIMENTAL GROUP  PLACEBO GROUP  
 Pre-
Ingestion 
Post-
Ingestion 
Sig. Pre-
Ingestion 
Post-
Ingestion 
Sig. 
HCT (%) 41,74±2,96 41,33±2,26 0,445 41,99±2,3
1 
41,73±1,73 0,779 
Hb (g/dL) 13,84±0,88 13,41±0,72 0,114 14,12±0,5
1 
13,60±0,66 0,050 
RC (x10 ̑ 
3/uL) 
4,91±0,31 4,86±0,30 0,333 4,89±0,28 4,96±0,33 0,889 
MCV (fL) 85,03±3,03 85,17±3,18 0,507 85,87±2,9
9 
85,62±2,89 0,237 
HCT: haematocrit; Hb: haemoglobin; RC: red cells; MCV: mean corpuscular volume 
    
There are no changes in haematocrit values in any of the two groups after the 
ingestion of substances. There are also no changes in other red cell 
parameters: haemoglobin, red blood cells or mean corpuscular volume in any 
group. 
 
Tables 4 and 5 show the ergometric parameters obtained from the incremental 
exercise test.  
 
Table 4. Ergoespirometric parameters in the Fat Max zone. 
VARIABL
E 
EXPERIMENTAL GROUP  PLACEBO GROUP  
 Pre-
Ingestion 
Post-
Ingestion 
Sig. Pre-
Ingestion 
Post-
Ingestion 
Sig. 
VO2 
(ml/min/k
g) 
19,60±2,59 18,10±3,41* 0,03
1 
25,25±12,1
5 
25,50±13 0,74
6 
VCO2  
(l/min) 
1,16±0,13 1,06±0,17* 0,038 1,43±0,57 1,50±0,60 0,123 
RER 0,85±0,07 0,82±0,06 0,092 0,84±0,04 0,86±0,05 0,207 
HR (ppm) 121,70±17,
88 
116,40±14,
28 
0,38
6 
126,12±31,
48 
120,00±24,
24 
0,17
6 
%HRR  55,10±12,5
9 
50,20±6,65 0,50
7 
56,50±21,2
1 
53,12±16,9
2 
0,39
5 
Power 
(W) 
105±15,81 105±10,54 1 131,25±47,
72 
134,38±51,
65 
0,31
7 
* p<0,05) comparing Pre-ingestion vs. Post-ingestion  
VO2: oxygen consumption; VCO2: carbon dioxide consumption; RER: respiratory quotient; HR: 
heart rate; %HRR: heart rate reserve percentage 
 
There are significant increases after sodium phosphate intake, oxygen uptake 
values (VO2) and carbon dioxide production (VCO2), not producing any change 
in these variables in the placebo group.  
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Table 5. Maximal ergoespirometric parameters 
VARIABL
E 
EXPERIMENTAL GROUP  PLACEBO GROUP  
 Pre-
Ingestion 
Post-
Ingestion 
Sig. Pre-
Ingestion 
Post-
Ingestion 
Sig. 
VO2 
(ml/min/k
g) 
47,09±10,3
6 
47,87±9,99  0,20
3 
53,71±4,67 52,74±8,2
2 
1 
VCO2  
(l/min) 
3,25 ± 0,42 3,36 ± 0,36 0,168 3,65 ± 0,56 3,89 ± 0,43 0,086 
RER 1,02 ± 0,03 1,01 ± 0,04 0,558 0,99 ± 0,05 1,01± 0,02 0,263 
HR (ppm) 184,20±7,3
8 
187,20±8,63 0,17
3 
186,88±7,4
3 
185,63±8,
4 
0,34
8 
Power 
(W) 
235,00±39,
44 
247,50±32,1
7* 
0,02
5 
275,00±55,
10 
290,63±5
5 
0,05
9 
* p<0,05) comparing Pre-ingestion vs. Post-ingestion 
VO2: oxygen consumption; VCO2: carbon dioxide consumption; RER: respiratory quotient; HR: 
heart rate 
 
There are no significant differences after intake on maximal oxygen 
consumption or maximum heart rate values in any of the two groups. However, 
after supplementation there is an increase in the maximum power output during 
the test in the experimental group.  
 
DISCUSSION 
 
Other research analysing the effects of sodium phosphate intake on body 
composition parameters is lacking. In this research project a decrease in body 
weight and BMI of subjects in the experimental group was observed. This may 
be caused by a general metabolic improvement which would increase tissue 
oxygenation and the ability to burn metabolic substrates, as suggested by 
Kreider et al. (1992). This could propose a potential ergogenic effect of sodium 
phosphate short term intake in fat mass decrease, which would be useful in 
sports requiring a mass reduction for performance (jumping, endurance sports) 
or to establish a category of competition as in combat sports (judo, taekwondo, 
etc.), yet this needs to be studied in more depth in future research. 
 
On the other hand, an analysis of blood parameters related to the red series 
such as haematocrit, haemoglobin, red blood cells and the mean corpuscular 
volumen, was conducted. The fact that, in Cade et al. (1984), Farber et al. 
(1987), Kreider et al. (1990, 1992), Folland et al. (2008) and, Czuba et al. 
(2008), there were improvements in metabolic regulation and oxygen 
consumption, leads us to believe that the study of red series is another possible 
way of improving aerobic performance. Not obtaining increases in these 
parameters before and after ingestion may be due to the fact that the increase 
in body temperature during exercise affects red blood cells. In addition, 
increasing the speed circulation would cause erythrocytes to collide, thus 
increasing the possibility of their destruction, or the stress produced during 
exercise would increase the fragility of red cell membranes (Terrados & Leibar, 
1995; cited in Legaz Arrese, 2000).  
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The data obtained in the Fatmax zone show that the experimental subjects 
lower their oxygen consumption and carbon dioxide production during this part 
of the test. This must be due to sodium phosphate intake, as these results were 
not experienced by the placebo group. As there is an absence of data from 
previous studies to compare with our own, it could be said that that these new 
results indicate that the experimental subjects achieved significant 
improvements in fat burning, improving energy efficiency, at least under the 
conditions and characteristics of our research. These results may be related to 
claims made by Jeukendrup, Saris & Wagenmakers (1998), who indicate that 
an enhanced ability to oxidise fatty acids is associated with improved 
performance.  
 
Research studies in scientific literature have followed the line of research 
initiated by Cade et al. (1984), revealing significant increases in VO2max, like in 
research carried out by Kreider et al. (1990), Stewart et al. (1990), Kreider et al. 
(1992) and Czuba et al. (2008). As in our results there are no changes in 
maximal oxygen consumption, our study provides evidence to the contrary, 
following the trend of the work of Folland et al. (2008), where changes in 
VO2max were not significant. The fact that there are no changes in this variable 
may be due to the lack of training of our subjects during the supplementation 
period, which did not occur in previous reviewed investigations, where the 
subjects were trained athletes who continued with their normal training regimen 
during the entire process. 
 
The increase in maximum power values of the experimental subjects leads us 
to talk about an improvement in the subjects’ performance and therefore an 
ergogenic effect. These are supported by data obtained in Stewart et al. (1990) 
and Kreider et al. (1992), where improvements were found in the reached 
power output and time of tests. There were also significant increases in average 
power, as in Folland, Stern & Brickley (2008). These enhancements may be 
due to a general metabolic improvement, to changes brought about by the 
action of 2,3 DPG (Cade et al., 1984). Body weight and BMI decreases may 
also affect the increased maximum power but these changes would be greater 
in other activities, where body weight had to be shifted, as may be the race on 
foot, if the tests had been conducted on a treadmill. 
 
CONCLUSIONS  
 
1. Sodium phosphate supplementation under the conditions of this research 
decreases body weight and BMI so that short-term intake is useful for 
sports activities whose performance depends on body weight. 
2. Sodium phosphate supplementation improves effort economy in the Fat 
Max zone, where major metabolic substrate for energy production is fat 
oxidation. 
3. Sodium phosphate supplementation may provide an ergogenic effect 
related to the maximum power developed in predominantly aerobic tests 
in untrained subjects and under the conditions of our research. 
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4. In the short term, sodium phosphate intake does not cause changes in 
blood parameters related to the red series, such as haematocrit, 
haemoglobin or red blood cells. 
5. Sodium phosphate intake does not alter VO2max values under the 
conditions of our research. 
 
RESEARCH LIMITATIONS 
 
In most of the research papers reviewed, such as Cade et al. (1984), Farber et 
al. (1984), Kreider et al. (1990), Stewart et al. (1990), Bremner et al. (2002), 
Czuba et al. (2008), cardiac parameters like serum phosphate concentration or 
2,3 DPG levels were studied. These parameters have not been analysed in our 
study, due to the lack of tools and techniques needed to carry out the analysis 
at the time of our research.  
 
For future research it would be preferable to extend the evaluation time of red 
blood series following a period of 'washing' without ingesting any substance. 
Then it would be possible to assess the potential creation of substances that 
allow an improvement in oxygen transport in the body. 
 
The possibility that subjects have experienced an improvement in psychological 
responses to exercise is also conceivable, due to the placebo effect, as the act 
of taking a substance may have allowed them to exercise at a greater intensity 
and / or for a longer duration, perceiving the same stress or being more 
motivated. 
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